UMR1152, "Physiopathology and Epidemiology of Respiratory Diseases" is a joint research unit under the joint supervision of Inserm and the University of Paris.
Inserm UMR1152 studies the risk factors and cellular and molecular mechanisms involved in the onset and progression of respiratory diseases, in particular asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis and pulmonary fibrosis, either of idiopathic origin (IPF) or associated with acute lung injury (ALI) and acute respiratory distress syndrome (ARDS).
What we do:
The projects proposed by the teams making up UMR 1152 are as follows:
Gain a better understanding of the cellular and molecular mechanisms involved in inflammation and lung remodeling in the respiratory diseases studied and their complications, in particular lung infections and acute and chronic lung rejection.
Identify genetic, biological and histopathological determinants to better characterize or identify new patient phenotypes
Test new therapeutic strategies designed to prevent or treat lung inflammation, remodeling and accompanying respiratory dysfunction.
Loading...
No documents found
Sorry, no items found. Please adjust your search criteria and try again.
